FORUM MARKETS Inc (FRMM): Nasdaq/NYSE listing notice — 180 Life Sciences receives Nasdaq delisting notice after failing to meet equity requirement

FORUM MARKETS Inc

Company failed to regain compliance with Nasdaq's minimum $2.5M stockholders' equity by May 13, 2024 deadline.
Received delist determination letter on May 14, 2024; trading suspension scheduled for May 23, 2024 unless appeal.
Intends to request a hearing before Nasdaq Hearings Panel, which would stay delisting pending process.
Also notified of non-compliance with audit committee composition (need three independent directors); cure period until May 2025.
Common stock (ATNF) and warrants (ATNFW) will continue trading on Nasdaq pending hearing outcome.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

November 15, 2023, the Listing Qualifications department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notified 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) that we did not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in Nasdaq Listing Rule 5550(b) (the “ Rule ”). Nasdaq provided the Company until January 2, 2024 to submit to Nasdaq a plan to regain compliance. We submitted the plan to regain compliance in a timely manner, and on January 11, 2024, Nasdaq advised the Company that it has determined to grant the

View on SEC.gov

Browse all listing & compliance notices →

FORUM MARKETS Inc filing history →

Source: SEC EDGAR

accession 0001213900-24-043761

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.